This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Sep;78(3):468.

doi: 10.1053/j.ajkd.2021.03.029. Epub 2021 Jun 11.

Verinurad/Febuxostat and Nephrotoxicity

Raul Fernandez-Prado¹, Alberto Ortiz¹

Affiliations

PMID: 34126127
DOI: 10.1053/j.ajkd.2021.03.029

Comment

Verinurad/Febuxostat and Nephrotoxicity

Raul Fernandez-Prado et al. Am J Kidney Dis. 2021 Sep.

. 2021 Sep;78(3):468.

doi: 10.1053/j.ajkd.2021.03.029. Epub 2021 Jun 11.

Authors

Raul Fernandez-Prado¹, Alberto Ortiz¹

Affiliation

¹ Fundacion Jimenez Diaz Hospital, Madrid, Spain.

PMID: 34126127
DOI: 10.1053/j.ajkd.2021.03.029

No abstract available

PubMed Disclaimer

Comment in

In Reply to 'Verinurad/Febuxostat and Nephrotoxicity'.
Stack AG, Erlandsson F, Terkeltaub R. Stack AG, et al. Am J Kidney Dis. 2021 Sep;78(3):468-469. doi: 10.1053/j.ajkd.2021.05.009. Epub 2021 Jun 11. Am J Kidney Dis. 2021. PMID: 34126126 No abstract available.

Comment on

Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients With Type 2 Diabetes: A Randomized Trial.
Stack AG, Dronamraju N, Parkinson J, Johansson S, Johnsson E, Erlandsson F, Terkeltaub R. Stack AG, et al. Am J Kidney Dis. 2021 Apr;77(4):481-489. doi: 10.1053/j.ajkd.2020.09.009. Epub 2020 Oct 29. Am J Kidney Dis. 2021. PMID: 33130235 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science